Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-11-07 | James C. Czirr, Chairman of the Board since February 2009... Mr. Czirr received a B.B.A. degree from the University of Michigan. |
| 2018-04-11 | Mr. Czirr received a B.B.A. degree from the University of Michigan and was involved in early stage development of biotech companies. |
| 2019-10-17 | Mr. Czirr received a B.B.A. degree from the University of Michigan. We believe that Mr. Czirr is best situated to sit on our Board because he is the director who was a co-founder of the Company and is familiar with our business and industry. |
| 2020-10-19 | Mr. Czirr received a B.B.A. degree from the University of Michigan. ... Mr. Czirr was instrumental in the early stage development of Safe Science Inc., a developer of anti-cancer drugs; served from 2005 to 2008 as Chief Executive Officer of Minerva Biotechnologies Corporation, a developer of nano particle bio chips ... |
| 2021-10-12 | Mr. Czirr received a B.B.A. degree from the University of Michigan. He was a co-founder of Galectin Therapeutics and has experience in biotech and mining companies, but no software-related skills are indicated. |
| 2022-10-17 | Mr. Czirr was instrumental in the early-stage development of Safe Science Inc., a developer of anti-cancer drugs; served as CEO of Minerva Biotechnologies Corporation. |
Data sourced from SEC filings. Last updated: 2026-02-03